blockers had no effect on the level of plasmainsulin at baseline and after stimulation of the significant effect. in theory,the selective beta blocker of beta 1 receptor is higher, its effect on glucoseand lipid metabolism is small, but with the increase of dose, selective betablockers remain...
p肾上腺素能受体阻滞剂在心血管疾病应用专家共识中华医学会心血管病学分会中华心血管病杂志编辑委员会前言B肾上腺素能受体阻滞剂( B阻滞剂) 自20世纪60年代以来已广泛应用于临床医学的各个领域,尤其心血管疾病的防治,其主要发明者也因此获得了诺贝尔生理学或医学奖。在心力衰竭( H F) 、高血压、冠心病、心律失常...
摘要: 背景特发性震颤(Essential tremor,ET)是最常见的运动障碍之一,目前尚无法治愈.Beta肾上腺素能阻滞剂是治疗ET的常用药物之一.关于其治疗ET的临床随机对照试验结果尚存争议,需进行进一步证据评价.目的对已有的关于Beta肾上腺素能阻滞剂治疗ET的随机对照试验进行系统评价,了解其有效性 展开 关键词: 神经病学 会...
β 肾上腺素能受体阻滞剂用于高血压治疗共识.中国(Beta adrenergic receptor blockers for hypertension treatment consensus. China) β 肾上腺素能受体阻滞剂用于高血压治疗共识.中国(Beta adrenergic receptor blockers for hypertension treatment consensus. China) Beta adrenergic receptor blockers for hypertension ...
(Beta adrenergic receptor blockers for hypertension treatment consensus. China)Beta adrenergic receptor blockers for the treatment of hypertensionExpert consensus in ChinaIn recent years, published large clinical trials such as ASCOT and LIFE, and the Swedish scholar Lindholm in 2005 published a meta-...